Cargando…

Advantages of Dose-Dense Methotrexate Protocol for Primary Central Nervous System Lymphoma: Comparison of Two Different Protocols at a Single Institution

The efficacy and toxicity of high-dose methotrexate (HD-MTX)-based chemotherapy were retrospectively reviewed in patients with primary central nervous system lymphoma (PCNSL). All immunocompetent patients with histologically or radiographically diagnosed PCNSL treated between 2006 and 2012 at Niigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoki, Hiroshi, Ogura, Ryosuke, Tsukamoto, Yoshihiro, Okada, Masayasu, Natsumeda, Manabu, Isogawa, Mizuho, Yoshida, Seiichi, Fujii, Yukihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Neurosurgical Society 2013
Materias:	Special Theme Topic: Treatment of Malignant Brain Tumor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508721/ https://www.ncbi.nlm.nih.gov/pubmed/24162244 http://dx.doi.org/10.2176/nmc.oa2013-0195

Ejemplares similares

Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
por: Onishi, Manabu, et al.
Publicado: (2013)

Treatment Results of Glioblastoma during the Last 30 Years in a Single Institute
por: Kumabe, Toshihiro, et al.
Publicado: (2013)

Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials
por: Mineharu, Yohei, et al.
Publicado: (2013)

New Treatment Strategies to Eradicate Cancer Stem Cells and Niches in Glioblastoma
por: Hide, Takuichiro, et al.
Publicado: (2013)

Usefulness of FMISO—PET for Glioma Analysis
por: Kobayashi, Hiroyuki, et al.
Publicado: (2013)

Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma
por: Arakawa, Yoshiki, et al.
Publicado: (2013)

ET-6 EFFICACY OF NEAR-INFRARED PHOTOIMMUNOTHERAPY TARGETING PODOPLANIN IN MALIGNANT GLIOMAS
por: Natsumeda, Manabu, et al.
Publicado: (2022)

GEN-7 Liquid biopsy in brain tumor patients -The present and future-
por: Natsumeda, Manabu, et al.
Publicado: (2021)

Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide
por: Eda, Takeyoshi, et al.
Publicado: (2022)

ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
por: Natsumeda, Manabu, et al.
Publicado: (2019)

Study protocol for a multicenter randomized controlled pilot study on decompressive laparotomy vs. decompressive craniectomy for intractable intracranial pressure after traumatic brain injury: The SCALPEL study
por: Kölbel, Benny, et al.
Publicado: (2023)

STMO-16 The usability of Detailed pre-operative 3D simulation image for Tumor Resection of High grade glioma
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2021)

COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019)

SPDR-4 SLFN11 RENDERS MEDULLOBLASTOMA SENSITIVE TO DNA DAMAGE CHEMOTHERAPIES
por: Nakata, Satoshi, et al.
Publicado: (2022)

Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety
por: Vitanza, Nicholas A., et al.
Publicado: (2023)

Unsupervised machine learning using K-means identifies radiomic subgroups of pediatric low-grade gliomas that correlate with key molecular markers
por: Haldar, Debanjan, et al.
Publicado: (2022)

Interdisciplinary care of children with diffuse midline glioma
por: Coleman, Christina, et al.
Publicado: (2022)

Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review
por: Lehner, Kurt R., et al.
Publicado: (2022)

Current state of pediatric neuro-oncology imaging, challenges and future directions
por: Nabavizadeh, Ali, et al.
Publicado: (2023)

Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma
por: Parsels, Leslie A., et al.
Publicado: (2023)

Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement
por: Waanders, Angela, et al.
Publicado: (2023)

Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.
por: Hwang, Eugene I., et al.
Publicado: (2023)

The promise of metabolic imaging in diffuse midline glioma
por: Lovibond, Samantha, et al.
Publicado: (2023)

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
por: Foster, Jessica B., et al.
Publicado: (2023)

Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease
por: Marshall, Emily, et al.
Publicado: (2023)

ACT-05 Present and future of precision-based medicine using cancer genome panels
por: Natsumeda, Manabu, et al.
Publicado: (2020)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report
por: Mouri, Yoshihiro, et al.
Publicado: (2022)

Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)
por: Perez-Garcia, Luis Fernando, et al.
Publicado: (2023)

Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy
por: Natsumeda, Manabu, et al.
Publicado: (2014)

Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
por: Natsumeda, Manabu, et al.
Publicado: (2021)

EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma
por: NOZAWA, Takanori, et al.
Publicado: (2019)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

Deep gray matters iron deposition is positively associated with white matter hyperintensity in hypertension
por: Su, Yu, et al.
Publicado: (2023)

Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas
por: On, Jotaro, et al.
Publicado: (2021)

Clinical Feasibility of Automated Brain Tissue and Myelin Volumetry of Normal Brian Using Synthetic Magnetic Resonance Imaging With Fast Imaging Protocol: A Single-Center Pilot Study
por: Zheng, Zuofeng, et al.
Publicado: (2023)

Management protocols for chronic heart failure in India
por: Mishra, S., et al.
Publicado: (2018)

Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing
por: Wei, Jun, et al.
Publicado: (2014)

Are patients open to elective re-sampling of their glioblastoma? A new way of assessing treatment innovations
por: Mir, Taskia, et al.
Publicado: (2014)

Usefulness of 5-ALA (Gliolan®)-derived PPX fluorescence for demonstrating the extent of infiltration in atypical meningiomas
por: Wilbers, Eike, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sjevitj7aggqd07f4pb9qoh56d